TOP1 and viral infectious disease: In a recent study, Marazzi, et al. revealed that the inhibition of topoisomerase 1 (Top1), a factor known to activate bacterial and viral infection-induced gene programs [81], suppressed the lethal inflammation induced by SARS-CoV-2 in vitro and in vivo [12].